Gencurix Inc.
Develops and commercializes diagnostic solutions for precision medicine in oncology.
229000 | KO
Overview
Corporate Details
- ISIN(s):
- KR7229000005
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 구로구 디지털로 243 지하이시티 15층, 구로구
- Website:
- https://www.gencurix.com/eng/
- Sector:
- Manufacturing
Description
Gencurix Inc. is a molecular diagnostics company that develops and commercializes diagnostic solutions for precision medicine. The company's portfolio focuses primarily on oncology, offering prognostic, companion, and early detection tests. Key products include GenesWell BCT, a multigene prognostic test for early-stage breast cancer, and the GenesWell ddEGFR Mutation Test, a ddPCR-based companion diagnostic. Gencurix also utilizes its Droplex liquid biopsy platform for early cancer detection and develops diagnostic tests for infectious diseases. The company's core technologies include digital droplet PCR (ddPCR), real-time PCR, and liquid biopsy for analyzing circulating tumor cells (CTCs) and cell-free DNA (cfDNA).
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2018-10-02 00:00 |
주식매수선택권부여에관한신고
|
Korean | 20.7 KB |
Automate Your Workflow. Get a real-time feed of all Gencurix Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Gencurix Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Gencurix Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
